RE:RE:Caveat Emptor future InvestorsI listened to the last presentation a few times in the last weeks just to get a better feel.
Its very difficult to understand if anything is in the near term, especially due to Gilles past experience.
He clearly wanted to annouce that sales were great last year and 2021 would be a record year, then again the base business does not seem to attract any investor attention.
Many of the new research/product/trials are in early stages and won't see any attention for some time (atleast 6-12 months).
Remains Juvente, which has close to no potential. So that is scratched off.
And then the only glimmer of hope I see in the near term (a few months atleast), is that they announce construciton of the new commerical PGX plant with either: government funding, corporate partner or financing. How each of the 3 options would affect stock price is hard to predict.
All I am left with then in real terms is this 7 million in cash that sits in the bank account (at end of Q3, but that Gilles repeats in the last prensentation, so it is not clear if the amount is still 7 million at end of Q4) ... If they approach a canadian bank, with their "steady" cash flow and the cash at hand, I am sure they can get funded. Would the market appreciate this option? My guess is not. So I am really hoping Gilles steps down, or gives up on his stubborness and just partners with a much needed partner ASAP.